A Study of an Easy-to-Read Informed Consent for Bone Marrow Transplant Clinical Trials

Overview

About this study

The purpose of this study is to evaluate the effectiveness of an easy to read informed consent form compared to the standard consent, and to understand any barriers to the use of the new form.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Adult patients (≥ 18 years)
Speaking and reading proficiency in English (as most of this study's instruments have not been translated and validated in languages other than English)
Willing and able to provide informed consent
Stated willingness to comply with study procedures and reporting requirements
Further inclusion /exclusion criteria for the ETRIC randomized study will be the same as the eligibility criteria for the BMT CTN parent studies
- Refer to BMTCTN1101 (NCT01597778) Double Cord Versus Haploidentical, BMTCTN1203 (NCT02208037) Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls, and BMTCTN1301 (NCT02345850) Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease for detailed eligibility criteria

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Mark Litzow, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Mark Litzow, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials